Medical condition
Small Cell Lung Cancer
Small Cell Lung Cancer is a medical condition tracked by NovaPharmaNews across 12 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- nintedanib (OFEV) Antineoplastic and immunomodulating agents (L01)
- topotecan (HYCAMTIN) Antineoplastic and immunomodulating agents (L01)
- tislelizumab (TEVIMBRA) Antineoplastic and immunomodulating agents (L01)
- paclitaxel (PACLITAXEL ACCORD) Antineoplastic and immunomodulating agents (L01)
- mobocertinib (EXKIVITY) Antineoplastic and immunomodulating agents (L01)
- cemiplimab (LIBTAYO) Antineoplastic and immunomodulating agents (L01)
- lurbinectedin (ZEPZELCA) Antineoplastic and immunomodulating agents (L01)
- brigatinib (ALUNBRIG) Antineoplastic and immunomodulating agents (L01)
- bevacizumab (ABEVMY) Antineoplastic and immunomodulating agents (L01)
- pralsetinib (GAVRETO) Antineoplastic and immunomodulating agents (L01)
- binimetinib (MEKTOVI) Antineoplastic and immunomodulating agents (L01)
- afatinib (GIOTRIF) Antineoplastic and immunomodulating agents (L01)
